GSK share price falls, despite Ebola vaccine success September 8, 2014 Monkeys given an experimental Ebola vaccine developed by GSK were resistant to the deadly virus when infected with it five weeks later, trials have shown. The results of a drug trial, published in the journal Nature, show all of the monkeys not given the vaccine died within 6 days of infection, whereas the four [...]
GSK Ebola vaccine to be tested in UK August 28, 2014 An international consortium is fast-tracking an Ebola vaccine under development by the US National Institutes of Health (NIH) and GlaxoSmithKline, with human trials set to begin in the UK as early as September. The move follows a declaration by the World Health Organisation (WHO) that the Ebola outbreak in West Africa is a public [...]
GlaxoSmithKline to investigate fresh bribery claims in Syria August 12, 2014 GlaxoSmithKline is facing new bribery allegations in Syria, the latest in a string of accusations flung at the drugmaker from countries across the world. The FTSE 100-quoted company is accused of bribing Syrian doctors and officials to boost sales of its medicines, by offering cash, trips and free medical samples. The latest claims emerged after [...]
RBS chairman Sir Philip Hampton mulls move to head GlaxoSmithKline August 8, 2014 Sir Philip Hampton could jump ship to leading pharmaceutical firm GlaxoSmithKline after six years chairing RBS, it was reported yesterday. Neither is in any rush to replace its chairman – Glaxo’s chair Sir Christopher Gent expects to serve at the firm until the end of next year. He has served at the company for a [...]
Philip Hampton is being lined up to replace Sir Christopher Gent as GSK’s next chairman August 7, 2014 Sir Philip Hampton is being lined up to take the role of chairman at Britain’s biggest drug company Glaxosmithkline after exiting Royal Bank of Scotland, Sky News reports. It’s said that Hampton will join GSK as early as next month as a non-executive director or deputy chairman, moving into the chairman’s seat by 2015. GSK’s [...]
GSK says separate consumer business is possible July 27, 2014 The chief executive of GlaxoSmithKline has said that he is open to the idea of creating a breakaway consumer healthcare business, the FT reports. Sir Andrew Witty said that a breakup of the group would be reasonable if a time came when a standalone consumer business offered more value. He said that his [...]
GSK seeks regulatory approval for the first ever malaria vaccine July 24, 2014 British drugmaker GlaxoSmithKline (GSK) has developed the world's first anti-malaria vaccine, designed for use on children in Africa. If GSK acquires the regulatory approval it is currently seeking, it will mark a big step forward in the fight against the mosquito-borne parasitic disease, which currently kills over 600,000 people a year. Most of [...]
GSK cuts profit outlook as lung drug sales slow July 23, 2014 GLAXOSMITHKLINE (GSK) cut its full-year outlook yesterday after posting a 13 per cent decline in second-quarter sales, as it struggled to maintain its position in the significant lung drug market. The FTSE 100-listed pharmaceuticals giant posted a 25 per cent slump in core operating profit to £1.4bn in the second quarter, while turnover fell 13 [...]
London Report: Tesco share price falls to lowest in 10 years as GSK warns on earnings July 23, 2014 Shares in Tesco yesterday fell to their lowest level in almost a decade after the beleaguered supermarket issued a profit warning earlier this week and announced that chief executive Philip Clarke is stepping down. Tesco’s shares fell 0.49 per cent to 276p yesterday, down 4.6 per cent since Monday when Clarke’s exit was announced and [...]
GlaxoSmithKline share price plunges following a 14pc fall in profits July 23, 2014 No respite for GlaxoSmithKline. Shares in the pharmaceutical giant took a drubbing today, plummeting as much as 6.9 per cent after the drugmaker posted a 14 per cent fall in second quarter profits. Shares recovered slightly, closing down around five per cent. One of its key drugs, Avadir, a treatment for asthma, makes up around [...]